The anticancer effects of MPT0G211, a novel HDAC6 inhibitor, combined with chemotherapeutic agents in human acute leukemia cells

BACKGROUND: There are some limitations of standard chemotherapy for acute leukemia. Vincristine and doxorubicin are commonly used for acute leukemia, but they may induce serious side effects such as cardiomyopathy and neurotoxicity. Furthermore, chemotherapy resistance occurs more and more frequentl...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Clin Epigenetics
Päätekijät: Tu, Huang-Ju, Lin, Yi-Jyun, Chao, Min-Wu, Sung, Ting-Yi, Wu, Yi-Wen, Chen, Yi-Ying, Lin, Mei-Hsiang, Liou, Jing-Ping, Pan, Shiow-Lin, Yang, Chia-Ron
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: BioMed Central 2018
Aiheet:
Research
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6310984/
https://ncbi.nlm.nih.gov/pubmed/30594243
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13148-018-0595-8
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia